suPARnostic® is the only CE-IVD certified product range applied for clinical determination of suPAR in human plasma and serum. It enables healthcare professionals to make fast clinical decisions based on prognostic evidence across diseases.
A low suPAR level indicates a good prognosis and supports the decision to discharge the patient.
A high suPAR level indicates presence, progression and severity of disease, organ damage and risk of mortality, and supports further clinical attention.